Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer VP joins Antares

Bruce Freundlich appointed senior VP, medical

Antares Pharma has appointed Dr Bruce Freundlich as senior VP, medical.

Dr Freundlich has extensive experience in both academia and industry, including spells at Merck & Co, Wyeth and Pfizer.

During his time at Pfizer from 2009 to 2010 he served as VP, inflammation. He assumed the role after his previous company Wyeth - where he served as VP - global medical affairs, was taken over by Pfizer.

Most recently, he served as president of New Light Medical Consultants.

Antares Pharma has made several senior appointments in the past year, including a new VP, clinical development, and senior VP, pharma sales and marketing, as the company looks to commercialise Otrexup (methotrexate) for arthritis and advance the development of testosterone replacement therapy Vibex QS T.

“Everyone associated with Antares is excited about his joining the organisation at a time when we are establishing our own commercial presence in the rheumatology field,” said Dr Paul Wotton, CEO of Antares.

Dr Freundlich's experience in rheumatology includes his position as chief of clinical rheumatology at the University of Pennsylvania in the US.

6th November 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics